RFK Jr. targeted by Pharma’s $2 million lobbying blitz, memo shows

By Ethan Fowler | National File

A resurfaced leaked memo from the Biotechnology Innovation Organization (BIO), first revealed by Brownstone Institute, April 2025, details a $2 million campaign to lobby Congress for Robert F. Kennedy Jr.’s removal as HHS Secretary, highlighting Big Pharma’s ongoing desperation amid his MAHA reforms.

As Kennedy’s regulatory push intensifies, this old plot—now recirculated by Malone—exposes the industry’s fear of accountability, blending fear-mongering and surrogate influence in a bid to preserve profits over public health.

Why it matters: This memo underscores Big Pharma’s corrupt grip on health policy, where billions in vaccine profits clash with Kennedy’s drive for transparency and safety—threatening to unravel a system built on shortcuts and suppression, even as reforms gain momentum.

The revelation flows into the latest developments, showing how industry panic persists despite months of pushback.

Driving the news: Dr. Malone reposted the memo on X, reigniting scrutiny of BIO’s strategy to “go to The Hill and lobby that it is time for RFK Jr to go,” amid Kennedy’s ongoing reforms at HHS.

• BIO allocated $2 million for the “Why We Vaccinate” campaign, using “inspire and frighten” tactics to manipulate public and legislative sentiment.
• The plan involves surrogates like Dr. Mehmet Oz and Sen. Bill Cassidy to provide bipartisan cover without engaging Kennedy directly.
• Investors are fleeing the sector due to Kennedy’s “unpredictability,” prompting BIO to commit half its reserves to neutralize him.

These details transition into the background, reminding readers of the memo’s origins.

READ THE COMPLETE STORY AT NATIONAL FILE